Hope is on the horizon for children suffering from pneumonia
A drug normally used to prevent tissue rejection following organ transplants could be repurposed to help treat human metapneumovirus (HMPV) infection in children.
A drug normally used to prevent tissue rejection following organ transplants could be repurposed to help treat human metapneumovirus (HMPV) infection in children.
A class of metal-based compounds acts as a shield to protect cells from viruses new research has found.
Ten Griffith University research projects have been awarded a total of almost $7m in funding by the prestigious National Health...